nLIGHT target price cut to $50 from $90
LASR•Needham cut its target price for nLIGHT to $50 from $90.
Related News
VivoSim Labs partners with Chemveda to test AI-designed drug candidates in human tissue models
VIVS•
BioMarin Pharmaceutical: Oppenheimer cuts target price to $94 from $97
BMRN•
Chegg Q3 revenue falls as legacy business declines
CHGG•
NewAmsterdam Pharma attends Guggenheim, Stifel and Jefferies healthcare conferences
NAMS•
Research Solutions integrates Scite, Article Galaxy with Microsoft Copilot
RSSS•